Table 1 Demographic and clinical features of Parkinson’ disease patients
From: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
Sex | Age at examination | [C] mg/ml | Diag. | Disease duration (months) | Clinical subtype | UPDRS I | UPDRS II | UPDRS III | Hoen & Yahr | MMSE | |
|---|---|---|---|---|---|---|---|---|---|---|---|
#1 | M | 65 | 0.38 | PD | 7 | Tremble | 0 | 4 | 4 | 1 | 30 |
#2 | F | 56 | 0.46 | PD | 10 | Akinetic | 1 | 9 | 29 | 1 | 29 |
#3 | F | 68 | 0.51 | PD | 8 | Akinetic | 2 | 3 | 14 | 2 | 28 |
#4 | M | 60 | 0.34 | PD | 10 | Tremble | 0 | 5 | 6 | 1.5 | 30 |
#5 | M | 70 | 0.39 | PD | 9 | Tremble | 0 | 3 | 5 | 1 | 30 |
#6 | F | 70 | 0.41 | PD | 12 | Tremble | 1 | 5 | 7 | 2 | 27 |
#7 | F | 73 | 0.46 | PD | 8 | Tremble | 3 | 9 | 19 | 1 | 29 |
#8 | M | 56 | 0.30 | PD | - | Tremble | 3 | 5 | 26 | 2 | 30 |
#9 | F | 66 | 0.60 | PD | 13 | Tremble | 0 | 8 | 17 | 1 | 30 |
#10 | F | 82 | 0.16 | PD | 9 | Tremble | 2 | 10 | 14 | 1 | 27 |
#11 | M | 80 | 0.47 | PD | - | Akinetic | 1 | 7 | 22 | 1.5 | 29 |
#12 | F | 56 | 0.19 | PD + D | >12 | Akinetic | 7 | 20 | 34 | 2.5 | 22 |
5 M/7 F | 66.5 ± 8.3 | 0.39 ± 0.13 | |||||||||
m ± sd | m ± sd |